JAMA Dermatology is an international peer-reviewed journal that has been in continuous publication since 1882. It began publication by the American Medical Association in 1920 as Archives of Dermatology and Syphilology. The journal publishes material that helps in the development and testing of the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery. JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
Journal Frequency and Access. JAMA Dermatology is published online weekly, every Wednesday, and in 12 print/online issues a year. The journal receives over 5 million online visits annually and more than 4.8 million article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.
Editorial Information. The journal’s acceptance rate is 7%. The median time to first decision is 4 days, and 41 days with review. The journal's Impact Factor is 7.74, ranking high among all dermatology journals. All articles are published online first. Additional information on the types of articles published and editorial policies is available in the journal's Instructions for Authors.
Editorial Team. Kanade Shinkai, MD, PhD, UCSF Department of Dermatology, San Francisco, California, is the editor in chief. For a complete listing of the journal's Editors and Editorial Board, see Editors and Publishers.
Mission Statement: JAMA Dermatology publishes information concerning the skin, its diseases, and their treatment. Its mission is to explicate the structure and function of the skin and its diseases and the art of using this information to deliver optimal medical and surgical care to the patient. We attempt to enhance the understanding of cutaneous pathophysiology and improve the clinician's ability to diagnose and treat skin disorders. This journal has a particular interest in publishing clinical and laboratory studies that reveal new information pertinent to the interests and needs of the medical dermatologist, dermatologic surgeon, and all those concerned with state-of-the-art care of cutaneous disease. We believe that knowledge derived from well-designed clinical trials and studies of cost-effectiveness are especially important for improving the practice of dermatology. Studies that increase the understanding of the outcome of treatment or the means by which the burden of dermatologic disease can be measured and reduced to promote the health of patients with skin disease will receive special priority. The journal regularly publishes reports on clinical investigations, editorials, and systematic reviews with meta-analyses. It also features reports and discussions on clinicopathologic correlations; clinical disorders of unique didactic value; pharmacologic, medical, and surgical therapeutics; and ethical, moral, socioeconomic, and political issues.
ISSN 2168-6068 (Print)
ISSN 2168-6084 (Online)
Back to top
JAMA Dermatology publishes innovative, clinically relevant research that helps in the development and testing of the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery.
For more information, see JAMA Dermatology Instructions for Authors. Submit your manuscript at https://manuscripts.jamaderm.com.
Updated January 2021
JAMA Network attends a variety of medical conferences across specialties throughout the world.
Create a personal account or sign in to: